[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Contact ::
:: Volume 8, Issue 3 (12-2006) ::
2006, 8(3): 215-222 Back to browse issues page
Serum lipoprotein [LP(a)] levels in patients with diabetes mellitus and impaired glucose tolerance: an evaluation and comparison
Sadeghi-Khosrghi , Saadat , Menbachi , Ghaffari , Ghanbili
, sadeghi619@yahoo.com
Abstract:   (19283 Views)
Introduction: Lipoprotein (a) [Lp(a)] is known as an independent risk factor of atherosclerosis and changes in serum level of this molecule and other lipoproteins have been noticed in diabetic patients because the most important cause of death in these patients is related to their cardiovascular disorders. Moreover, patients with IGT (Impaired Glucose Tolerance) are more at risk of cardiovascular disease than the normal population. The main purpose of this study is to comparie Lp(a) serum levels between diabetic patients, patients with IGT and normal controls without any glucose metabolism disturbance. Materials and Methods: In this study, 180 patients (112 females, average age of 51±11 years and 68 males, average age of 54±14 years) were selected and placed in three separate age and sex matched groups (60 patients in each group) as Diabetic, IGT and Control group. After taking clinical history and determining body measurements, serum total cholesterol, triglyceride, HDL-C, LDL-C and Lp(a) were measured in fasting blood samples. Results: Lp(a) serum levels were not significantly different between the three groups. (DM:25.4±20.9, IGT: 24±21.4, Control: 24.6±17.9 mg/dL). An increase in serum triglyceride was found in the diabetic patients compared with the controls. (DM: 210.6±91.5, control: 159±71.9 mg/dL p=0.04). HDL-C levels showed no significant difference between groups. In addition, HDL-C levels of the all three groups were lower than the recommended range of Coronary Artery Disease prevention. (average range of the three groups: 37.4±8.7 mg/dL) Total Cholesterol and LDL-C serum levels were higher in diabetic patients compared with the controls. (DM: 222.3±35.4 vs Control group: 191.7±46.5 mg/dL p<0.007 and DM: 141.2±32.4 vs Control: 119.0±36.6 mg/dL p<0.03). In the IGT group, serum lipids levels were between the levels of the diabetic and control groups none of these differences were significant. Conclusion: This study shows that Lp(a) serum levels do not change in Diabetes Mellitus and IGT.
Keywords: Lipoprotein (a), Diabetes, IGT
Full-Text [PDF 346 kb]   (2135 Downloads)    
Type of Study: Original | Subject: Endocrinology
Received: 2007/02/8
Add your comments about this article
Your username or Email:

CAPTCHA code


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Sadeghi-Khosrghi, Saadat, Menbachi, Ghaffari, Ghanbili. Serum lipoprotein [LP(a)] levels in patients with diabetes mellitus and impaired glucose tolerance: an evaluation and comparison. Iranian Journal of Endocrinology and Metabolism. 2006; 8 (3) :215-222
URL: http://ijem.sbmu.ac.ir/article-1-330-en.html


Volume 8, Issue 3 (12-2006) Back to browse issues page
مجله ی غدد درون‌ریز و متابولیسم ایران، دو ماهنامه  پژوهشی مرکز تحقیقات غدد درون‌ریز و متابولیسم، Iranian Journal of Endocrinology and Metabolism
Persian site map - English site map - Created in 0.06 seconds with 33 queries by YEKTAWEB 3855